Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF

Loading...
Loading...

Cathie Wood‘s flagship ARK Innovation ETF ARKK has been navigating through significant losses, showcasing the challenges faced by some of its major holdings.

What Happened: Since its peak in February 2021, the fund has experienced substantial losses. The ARKK ETF has declined by 72% since its peak on Feb. 19, 2021. During this period, the Nasdaq 100, its primary benchmark, has surged by 39%, reaching record highs. Year-to-date, the ARKK ETF has decreased by 15%, while the Nasdaq 100 has increased by 12%.

Data from Cathie’s Ark, a platform monitoring ARK Invest’s ETFs’ daily trades, reveals that only Tesla Inc TSLA, among ARKK’s top 10 stock holdings, has shown a positive return since joining the portfolio. Additionally, out of the 35 stocks held in the portfolio, only seven are currently in positive territory.

These are the ten largest losers within the ARKK ETF, as per data from Cathie’s Ark:

  1. Ginkgo Bioworks
    The initial price of Ginkgo Bioworks Holdings Inc DNA was $9.99. Its current price stands at $0.66, reflecting a significant percentage change of -93.4%.
  2. Teladoc Health
    Teladoc Health Inc TDOC started at an initial price of $163.91. As of now, its price has dropped to $11.43, indicating a considerable percentage change of -93.0%.
  3. Pacific Biosciences
    Pacific Biosciences of California Inc PACB began at an initial price of $19.84. Currently, it is priced at $1.88, showing a substantial percentage change of -90.2%.
  4. 10x Genomics
    10X Genomics Inc TXG had an initial price of $153.19. Its current price is $22.67, resulting in a notable percentage change of -85.0%.
  5. Unity Technologies
    Unity Software Inc U started at an initial price of $104.43. It is currently priced at $19.37, indicating a significant percentage change of -81.2%.
  6. Verve Therapeutics
    Verve Therapeutics Inc VERV began at an initial price of $28.17. Its current price is $5.25, reflecting a substantial percentage change of -81.0%.
  7. Zoom Video
    Zoom Video Communications Inc ZM started at an initial price of $278.55. Its current price stands at $63.12, showing a noticeable percentage change of -77.6%.
  8. Roku
    Roku Inc ROKU had an initial price of $243.88. Its current price is $56.67, resulting in a significant percentage change of -77.0%.
  9. UiPath
    UiPath Inc PATH started at an initial price of $62.44. As of now, its price has dropped to $18.98, indicating a considerable percentage change of -69.5%.
  10. Intellia Therapeutics
    Intellia Therapeutics Inc NTLA began at an initial price of $62.04. Its current price stands at $24.67, reflecting a significant percentage change of -59.9%.

Why It Matters: Wood’s ARK Invest has been the subject of intense scrutiny in recent months. The firm’s performance has been a topic of debate, with some industry experts expressing skepticism about its investment strategies.

Wood’s views on the stock market have also sparked controversy, with her comparison of the current market to the Great Depression drawing criticism from renowned investor Jim Chanos.

Additionally, her prediction about the significance of crypto in the 2024 White House race has been a point of contention.

Read Next: Here’s How Much MAGA Coin Has Jumped Since The Ex-President Said, ‘If You’re In Favor Of Crypto, You Better Vote For Trump’

Cathie Wood Ark Invest. Image made via photos on Flickr and Shutterstock

This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EquitiesNewsShort SellersGlobalMarketsETFsARK Investbenzinga neuroCathie WoodJim ChanosKaustubh Bagalkote
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...